Profile Summary
Medical Qualification: MBBS, DNB, FRCR Clinical Oncology (UK)
Designation: Consultant, Radiation Oncology
Years of experience: 16+ years
Areas of expertise:
- Stereotactic Ablative Body Radiotherapy (SABR/SBRT) for Prostate cancer, Lung cancer, and Oligometastatic disease (up to five metastases in Stage IV cancers)
- Stereotactic Radiosurgery (SRS) and Stereotactic Radiotherapy (SRT) for brain tumors, meningiomas, schwannomas, and brain metastases
- Volumetric Modulated Arc Therapy (VMAT/RapidArc) ,Image-Guided Radiotherapy (IGRT) & Deep Inspiration Breath Hold (DIBH)
- Clinical Oncology & Immunotherapy Toxicity Management
- Comprehensive multidisciplinary cancer care
Introduction:
Dr. Mukul Roy completed advanced Fellowship training in the United Kingdom at James Cook University Hospital, South Tees NHS Foundation Trust and Newcastle University. Her fellowship was focused on advanced SABR/SBRT techniques for Prostate cancer, Lung cancer, and Oligometastatic disease (upto 5 metastatic sites in stage 4 cancer). She had been working at Jaslok Hospital prior to this and has more than 16 years experience in Radiation Oncology.
• She also undertook a prestigious Visiting Fellowship in the United States at the University of Massachusetts, Boston, and Long Beach Memorial Hospital, California, where she trained with internationally renowned experts Dr. Nisar Syed, pioneer of prostate brachytherapy and founder of the American Brachytherapy Society, and Dr. T. J. Fitzgerald in 2016.
• In India, she did fellowship training in Neuro-Oncology at Tata Memorial Hospital, Mumbai, under the guidance of Dr. Rakesh Jalali, one of the leading experts in the field.
❖ Dr. Roy has a strong academic and research interest in:
- Geriatric Oncology & patient centric management.
- Advanced Radiotherapy Techniques
- Artificial Intelligence in Oncology
- Cancer Outcomes Research & Quality Improvement in Healthcare
She has presented her work at national and international conferences and actively contributes to clinical audits, research initiatives, trainee education, and quality improvement programs. She is an international speaker and educator committed to advancing cancer care through innovation and collaboration.
Dr. Roy believes in combining evidence-based medicine with compassion, communication, and personalised treatment. Her approach focuses on empowering patients and families through informed decision-making while embracing technological advances that improve cancer outcomes and quality of life.
Outside clinical practice, Dr. Roy is passionate about healthcare innovation, leadership development, teamwork and mentoring the next generation of oncologists.
Awards & Publications:
Publications:
1. The Real-World Outcomes of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Multi-center Retrospective Study at BTOG, Edinburgh, March 2026
O. Okuma, R. Gul, M. Roy, O.Shahin, I. Gray, E. Aynsley, K. Yogalingam, S. Masinghe, T.Mansy, C.Peedell, L.Li
2.Quality cancer care for older adults from culturally and linguistically diverse backgrounds: Perspectives from the Cancer and Aging Research Group Junior Board.
Singhal, S., Abdallah, M., Phillips, T., Arrato, N. A., Roy, M., Werts-Pelter, S., Ramos, K., & Han, C. Y. (2026). Journal of geriatric oncology, 17(2), 102853. https://doi.org/10.1016/j.jgo.2026.102853
3. Perspectives on geriatric oncology research presented at the 2023 San Antonio Breast Cancer Symposium: A Young International Society of Geriatric Oncology report.Wing-Lok Chan, Mukul Roy,Hing-Wai Wong,Chiu-Ki Astor Mak, Chun-Yuet Janice Leung
4. Towards Precision Care: Integrating G8 and VES-13 Screening in Older Cancer Patients undergoing Radiation Therapy – Poster presentation at SIOG 2025, Ghent, Belgium
5. Inclusion, characteristics, and reporting of older adults in FDA registration studies of immunotherapy, 2018-2022.” Journal for immunotherapy of cancer vol. 12,8 e009258. 28 Aug. 2024, doi:10.1136/jitc-2024-009258
6. Highlighting selected research conducted in older patients presented at the European Society for Medical Oncology (ESMO) 2022 Congress – a Young International Society of Geriatric Oncology (SIOG) perspective
Baran Akagunduz, Bertha Alejandra Martinez-Cannon, Nabiel Mir, Rogelio N. Velasco, Mukul Roy, Gabor Liposits,Journal of Geriatric Oncology,Volume 14, Issue 2,2023,101413, https://doi.org/10.1016/j.jgo.2022.12.001.
7. Chan WL, Yeung TV, Roy M, Wong HW, Mak CA, Leung CJ. Perspectives on geriatric oncology research presented at the 2023 San Antonio Breast Cancer Symposium: A Young International Society of Geriatric Oncology report. J Geriatr Oncol. Published online April 26, 2024. doi:10.1016/j.jgo.2024.101769
8. Digital health in geriatric oncology: A Young International Society of Geriatric Oncology review. Mac Eochagain C, Senac NMG, Cavanagh M, Roy M, Ciccone AS, Contreras B, Testa GD, Velasco R, Marinho J, Serrano AG, Schiaffino MK, Gomes F. J Geriatr Oncol. 2023 Nov;14(8):101649. doi: 10.1016/j.jgo.2023.101649. Epub 2023 Oct 27. PMID: 38682324.
9. Systemic treatment for triple negative breast cancer in older patients: A Young International Society of Geriatric Oncology Review Paper.Journal of Geriatric Oncology, 2022-06-01, Volume 13, Issue 5, Pages 563-571 https://doi.org/10.1016/j.jgo.2022.01.002
10.Hypomethylating agent-based therapies in older adults with acute myeloid leukemia - A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee.J Geriatr Oncol. 2022 Nov 23:S1879-4068(22)00528-8.Neuendorff NR, Gagelmann N, Singhal S, Meckstroth S, Thibaud V, Zhao Y, Mir N, Shih YY, Amaro DMC, Roy M, Lombardo J, Gjærde LK, Loh KP.
doi: 10.1016/j.jgo.2022.11.005. Epub ahead of print. PMID: 36435726.
11. Anal cancer in older adults: A Young International Society of Geriatric Oncology review paper.Martinez-Cannon BA, Perez ACT, Hincapie-Echeverri J, Roy M, Marinho J, Buerba GA, Akagunduz B, Li D, Soto-Perez-de-Celis E.Journal of Geriatric Oncology 13 (2022) 914–923 https://doi.org/10.1016/j.jgo.2022.01.002
12. Highlighting selected research conducted in older patients presented at the 23rd European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer (2021): Young International Society of Geriatric Oncology Report.Journal of Geriatric Oncology, 2022-01-01, Volume 13, Issue 1, Pages 4-6 https://doi.org/10.1016/j.jgo.2021.10.006
13. Preliminary results in IGRT in Head and Neck Squamous cell carcinomas: Jaslok Hospital experience at European Cancer Congress held at Stockholm, September 2011.European Journal of Cancer Volume 47, Supplement 1, Page S566,September 2011
14. Co-authored chapter Radiotherapy: Retrospects and Prospects in Radiotherapy in book “Practical Clinical Oncology” with Dr.Nagraj G.Huilgol (Chief Editor- Dr. Praful Desai)
Memberships:
Memberships:
• Fellow , Royal College of Radiologists, RCR, London, UK
• European Society for RadioTherapy and Oncology (ESTRO)
• American society for Radiation Oncology – (ASTRO)
• International Society of Geriatric Oncology (SIOG) – Governance committee of Young SIOG
• American Society of Clinical Oncology (ASCO)
• European Society of Medical Oncology (ESMO)
• CARG - Cancer and Aging Research Group, USA – Clinical Implementation Core and Junior CARG Board member